These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 974273)

  • 1. Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
    Girolami A; Patrassi G; Burul A
    Blut; 1976 Jul; 33(1):41-8. PubMed ID: 974273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.
    Girolami A; Patrassi G; Fabris F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):283-93. PubMed ID: 69593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.
    Girolami A; Brunetti A; Patrassi GM
    Am J Clin Pathol; 1977 Jan; 67(1):57-60. PubMed ID: 831455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
    Girolami A; Dal Bo Zanon R; Sticchi A
    Blut; 1977 Sep; 35(3):247-52. PubMed ID: 912109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
    Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
    Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
    Moscarella S; Ventimiglia V
    Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
    Girolami A; Patrassi O; Cella G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):463-70. PubMed ID: 72033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the significance of differences between thrombotest and normotest in the study of coumarin plasma.
    Girolami A
    Haemostasis; 1989; 19(4):241-4. PubMed ID: 2807042
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a lyophilized reference plasma to compare coagulation test procedures: Normotest, Simplastin-A and Thrombotest.
    Kahan J; Norén I
    Thromb Diath Haemorrh; 1975 Nov; 34(2):426-44. PubMed ID: 1198406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.
    Girolami A; Fabris F; dal Bo Zanon R; Cappellato G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(5):670-6. PubMed ID: 75136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple method for determination of the factor VII-phospholipid complex using Normotest.
    Dalaker K; Janson TL; Johnsen B; Skartlien AH; Prydz H
    Thromb Res; 1987 Aug; 47(3):287-93. PubMed ID: 3629556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional quality control of coagulation assay procedures (normotest, simplastin-a and thrombotest).
    Kahan J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):79-89. PubMed ID: 4454048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X].
    Pagliano FM; Cestari G; Slucca P
    Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolongation of the thrombotest clotting time in newborns.
    Hamulyák K; Devilée PP; Nieuwenhuizen W; Hemker HC
    Thromb Res; 1988 Oct; 52(1):45-52. PubMed ID: 3201395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against the presence of "inhibitors" in coumarin treated patients.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):523-9. PubMed ID: 83274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.